121 related articles for article (PubMed ID: 31762177)
21. Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma.
Oikawa Y; Morita KI; Kayamori K; Tanimoto K; Sakamoto K; Katoh H; Ishikawa S; Inazawa J; Harada H
Cancer Sci; 2017 Feb; 108(2):256-266. PubMed ID: 27889930
[TBL] [Abstract][Full Text] [Related]
22. PDGFRA mRNA overexpression is associated with regional metastasis and reduced survival in oral squamous cell carcinoma.
Ong HS; Gokavarapu S; Tian Z; Li J; Xu Q; Zhang CP; Cao W
J Oral Pathol Med; 2018 Aug; 47(7):652-659. PubMed ID: 29660835
[TBL] [Abstract][Full Text] [Related]
23. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
24. Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.
Chen R; Jin G; Li W; McIntyre TM
J Immunol; 2018 Oct; 201(7):2154-2164. PubMed ID: 30150285
[TBL] [Abstract][Full Text] [Related]
25. Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas.
Chiang WF; Liu SY; Yen CY; Lin CN; Chen YC; Lin SC; Chang KW
Oral Oncol; 2008 Mar; 44(3):270-6. PubMed ID: 17468034
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data.
Szturz P; Budíková M; Vermorken JB; Horová I; Gál B; Raymond E; de Gramont A; Faivre S
Oral Oncol; 2017 Nov; 74():68-76. PubMed ID: 29103754
[TBL] [Abstract][Full Text] [Related]
27. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
[TBL] [Abstract][Full Text] [Related]
28. Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC).
Auzair LB; Vincent-Chong VK; Ghani WM; Kallarakkal TG; Ramanathan A; Lee CE; Rahman ZA; Ismail SM; Abraham MT; Zain RB
Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1885-93. PubMed ID: 26138391
[TBL] [Abstract][Full Text] [Related]
29. EGFR protein overexpression and mutation in areca quid-associated oral cavity squamous cell carcinoma in Taiwan.
Huang SF; Chuang WY; Chen IH; Liao CT; Wang HM; Hsieh LL
Head Neck; 2009 Aug; 31(8):1068-77. PubMed ID: 19360742
[TBL] [Abstract][Full Text] [Related]
30. Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma.
Ma J; Tang X; Sun WW; Liu Y; Tan YR; Ma HL; Zhu DW; Wang M; Wang LZ; Li J; Tu YY; Zhang CP; Zhang ZY; Zhong LP
Oncotarget; 2016 Jan; 7(2):2113-22. PubMed ID: 26544895
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of EGFR in prognostic characterization in histopathological variants of oral squamous cell carcinoma.
Tyagi D; Singhal M; Gulati N; Jain A; Shetty DC
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S743-S746. PubMed ID: 38384049
[TBL] [Abstract][Full Text] [Related]
32. Midkine and NANOG Have Similar Immunohistochemical Expression Patterns and Contribute Equally to an Adverse Prognosis of Oral Squamous Cell Carcinoma.
Kim HM; Kang YH; Byun JH; Jang SJ; Rho GJ; Lee JS; Park BW
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113102
[TBL] [Abstract][Full Text] [Related]
33. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
34. Coexpression of SGLT1 and EGFR is associated with tumor differentiation in oral squamous cell carcinoma.
Hanabata Y; Nakajima Y; Morita K; Kayamori K; Omura K
Odontology; 2012 Jul; 100(2):156-63. PubMed ID: 21607591
[TBL] [Abstract][Full Text] [Related]
35. Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas.
Bánkfalvi A; Krassort M; Végh A; Felszeghy E; Piffkó J
J Oral Pathol Med; 2002 Sep; 31(8):450-7. PubMed ID: 12220351
[TBL] [Abstract][Full Text] [Related]
36. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
[TBL] [Abstract][Full Text] [Related]
38. Amplification of EGFR and cyclin D1 genes associated with human papillomavirus infection in oral squamous cell carcinoma.
Chuerduangphui J; Pientong C; Patarapadungkit N; Chotiyano A; Vatanasapt P; Kongyingyoes B; Promthet S; Swangphon P; Bumrungthai S; Pimson C; Ekalaksananan T
Med Oncol; 2017 Sep; 34(9):148. PubMed ID: 28741068
[TBL] [Abstract][Full Text] [Related]
39. Tumor budding is associated with poor prognosis of oral squamous cell carcinoma and histologically represents an epithelial-mesenchymal transition process.
Hong KO; Oh KY; Shin WJ; Yoon HJ; Lee JI; Hong SD
Hum Pathol; 2018 Oct; 80():123-129. PubMed ID: 29936060
[TBL] [Abstract][Full Text] [Related]
40. MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.
Beau-Faller M; Ruppert AM; Voegeli AC; Neuville A; Meyer N; Guerin E; Legrain M; Mennecier B; Wihlm JM; Massard G; Quoix E; Oudet P; Gaub MP
J Thorac Oncol; 2008 Apr; 3(4):331-9. PubMed ID: 18379349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
